This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Santolecan Pharmaceuticals LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Haijun Cheng: Innovator in Drug Delivery Systems
Introduction
Haijun Cheng is a notable inventor based in Tiantang Town, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. His innovative work focuses on the development of novel conjugates that enhance the efficacy of drug delivery.
Latest Patents
Haijun Cheng holds a patent for "Taxane-lipid-polysaccharide dual conjugates, preparation methods thereof and uses thereof." This invention pertains to a group of taxane-lipid-polysaccharide dual conjugates of the Formula I. It includes a process for their preparation, their uses, and pharmaceutical compositions comprising these conjugates. The invention also relates to a series of intermediates for the preparation of taxane-lipid-polysaccharide dual conjugates, along with their use as drug delivery vehicles. He has 1 patent to his name.
Career Highlights
Cheng is currently associated with Santolecan Pharmaceuticals LLC, where he continues to advance his research in drug delivery systems. His work is pivotal in developing new methods that can potentially improve therapeutic outcomes for patients.
Collaborations
Some of his notable coworkers include Jinghua Hu and Xiaohai Li, who contribute to the collaborative efforts in their research projects.
Conclusion
Haijun Cheng's innovative work in drug delivery systems exemplifies the importance of research and development in pharmaceuticals. His contributions are paving the way for more effective treatment options in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile